Client & Alumni News

Saladax Submits its Rapid Blood Test for Determining Medication Adherence to FDA

Saladax Biomedical Inc. submitted a De Novo classification request to the U.S. Food and Drug Administration for the MyCare Psychiatry™ Total Risperidone Assay Kit. The tests will let medical personnel identify levels of antipsychotic drugs in a patient’s body in one hour, enabling them to better assess patient adherence, which is a critical unmet need. More: https://bit.ly/2LjozaU